CA Stock MarketDetailed Quotes

Entheon Biomedical Corp (ENBI)

Watchlist
  • 0.100
  • 0.0000.00%
15min DelayMarket Closed Dec 18 15:06 ET
1.39MMarket Cap-10.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Entheon Biomedical Corp (ENBI) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Feb 28, 2026
(FY)Nov 30, 2025
(Q4)Nov 30, 2025
(Q3)Aug 31, 2025
(Q2)May 31, 2025
(Q1)Feb 28, 2025
(FY)Nov 30, 2024
(Q4)Nov 30, 2024
(Q3)Aug 31, 2024
(Q2)May 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
51.28%-54.24K
11.52%-314.66K
34.45%-60.38K
61.48%-27.17K
-17.80%-115.78K
-17.55%-111.33K
1.19%-355.64K
-97.77%-92.11K
52.27%-70.54K
-515.05%-98.28K
Net income from continuing operations
31.51%-99.72K
-1.92%-324.01K
22.43%-65.01K
27.20%-47.11K
29.90%-66.29K
-94.51%-145.61K
-5.97%-317.92K
-12.39%-83.8K
50.17%-64.7K
---94.56K
Remuneration paid in stock
----
--2.72K
--0
--0
----
----
--0
--0
--0
----
Change In working capital
32.71%45.49K
117.60%6.64K
155.76%4.63K
441.63%19.93K
-1,302.55%-52.2K
272.64%34.28K
33.50%-37.72K
-125.66%-8.31K
76.77%-5.84K
-121.40%-3.72K
-Change in receivables
425.21%6.14K
-316.31%-4.31K
-392.13%-876
9,350.00%3.52K
-308.66%-5.06K
-770.05%-1.89K
-94.45%1.99K
-103.90%-178
99.00%-38
-96.80%2.43K
-Change in prepaid assets
-25.92%9.28K
261.82%21.01K
79.02%-5.82K
-9.31%14.11K
-94.11%195
-14.70%12.52K
124.95%5.81K
-63.71%-27.75K
-42.65%15.56K
4.45%3.31K
-Change in payables and accrued expense
27.19%30.07K
77.90%-10.06K
-42.26%11.33K
110.80%2.31K
-400.38%-47.34K
168.90%23.64K
34.34%-45.52K
-56.16%19.62K
55.93%-21.36K
84.67%-9.46K
Cash from discontinued investing activities
Operating cash flow
51.28%-54.24K
11.52%-314.66K
34.45%-60.38K
61.48%-27.17K
-17.80%-115.78K
-17.55%-111.33K
1.19%-355.64K
-97.77%-92.11K
52.27%-70.54K
-515.05%-98.28K
Investing cash flow
Cash flow from continuing investing activities
0
0
Net investment purchase and sale
----
----
----
----
----
----
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
----
----
----
----
----
----
--0
--0
----
----
Financing cash flow
Cash flow from continuing financing activities
0
238.98%500K
0
0
0
500K
147.5K
0
0
147.5K
Net common stock issuance
--0
238.98%500K
--0
--0
--0
--500K
--147.5K
--0
--0
--147.5K
Net other financing activities
----
----
----
----
----
----
--147.5K
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
238.98%500K
--0
--0
--0
--500K
--147.5K
--0
--0
--147.5K
Net cash flow
Beginning cash position
135.79%321.84K
-60.39%136.49K
67.20%382.21K
36.86%409.38K
110.13%525.16K
-60.39%136.49K
-49.33%344.63K
-40.13%228.6K
-39.07%299.14K
-49.09%249.92K
Current changes in cash
-113.95%-54.24K
189.05%185.34K
34.45%-60.38K
61.48%-27.17K
-335.24%-115.78K
510.37%388.67K
37.97%-208.14K
-147.75%-92.11K
35.35%-70.54K
--49.22K
End cash Position
-49.04%267.6K
135.79%321.84K
135.79%321.84K
67.20%382.21K
36.86%409.38K
110.13%525.16K
-60.39%136.49K
-60.39%136.49K
-40.13%228.6K
-39.07%299.14K
Free cash from
51.28%-54.24K
11.52%-314.66K
34.45%-60.38K
61.48%-27.17K
-17.80%-115.78K
-17.55%-111.33K
1.19%-355.64K
-97.77%-92.11K
52.27%-70.54K
-515.05%-98.28K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unaudited
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Feb 28, 2026(FY)Nov 30, 2025(Q4)Nov 30, 2025(Q3)Aug 31, 2025(Q2)May 31, 2025(Q1)Feb 28, 2025(FY)Nov 30, 2024(Q4)Nov 30, 2024(Q3)Aug 31, 2024(Q2)May 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 51.28%-54.24K11.52%-314.66K34.45%-60.38K61.48%-27.17K-17.80%-115.78K-17.55%-111.33K1.19%-355.64K-97.77%-92.11K52.27%-70.54K-515.05%-98.28K
Net income from continuing operations 31.51%-99.72K-1.92%-324.01K22.43%-65.01K27.20%-47.11K29.90%-66.29K-94.51%-145.61K-5.97%-317.92K-12.39%-83.8K50.17%-64.7K---94.56K
Remuneration paid in stock ------2.72K--0--0----------0--0--0----
Change In working capital 32.71%45.49K117.60%6.64K155.76%4.63K441.63%19.93K-1,302.55%-52.2K272.64%34.28K33.50%-37.72K-125.66%-8.31K76.77%-5.84K-121.40%-3.72K
-Change in receivables 425.21%6.14K-316.31%-4.31K-392.13%-8769,350.00%3.52K-308.66%-5.06K-770.05%-1.89K-94.45%1.99K-103.90%-17899.00%-38-96.80%2.43K
-Change in prepaid assets -25.92%9.28K261.82%21.01K79.02%-5.82K-9.31%14.11K-94.11%195-14.70%12.52K124.95%5.81K-63.71%-27.75K-42.65%15.56K4.45%3.31K
-Change in payables and accrued expense 27.19%30.07K77.90%-10.06K-42.26%11.33K110.80%2.31K-400.38%-47.34K168.90%23.64K34.34%-45.52K-56.16%19.62K55.93%-21.36K84.67%-9.46K
Cash from discontinued investing activities
Operating cash flow 51.28%-54.24K11.52%-314.66K34.45%-60.38K61.48%-27.17K-17.80%-115.78K-17.55%-111.33K1.19%-355.64K-97.77%-92.11K52.27%-70.54K-515.05%-98.28K
Investing cash flow
Cash flow from continuing investing activities 00
Net investment purchase and sale --------------------------0------------
Cash from discontinued investing activities
Investing cash flow --------------------------0--0--------
Financing cash flow
Cash flow from continuing financing activities 0238.98%500K000500K147.5K00147.5K
Net common stock issuance --0238.98%500K--0--0--0--500K--147.5K--0--0--147.5K
Net other financing activities --------------------------147.5K------------
Cash from discontinued financing activities
Financing cash flow --0238.98%500K--0--0--0--500K--147.5K--0--0--147.5K
Net cash flow
Beginning cash position 135.79%321.84K-60.39%136.49K67.20%382.21K36.86%409.38K110.13%525.16K-60.39%136.49K-49.33%344.63K-40.13%228.6K-39.07%299.14K-49.09%249.92K
Current changes in cash -113.95%-54.24K189.05%185.34K34.45%-60.38K61.48%-27.17K-335.24%-115.78K510.37%388.67K37.97%-208.14K-147.75%-92.11K35.35%-70.54K--49.22K
End cash Position -49.04%267.6K135.79%321.84K135.79%321.84K67.20%382.21K36.86%409.38K110.13%525.16K-60.39%136.49K-60.39%136.49K-40.13%228.6K-39.07%299.14K
Free cash from 51.28%-54.24K11.52%-314.66K34.45%-60.38K61.48%-27.17K-17.80%-115.78K-17.55%-111.33K1.19%-355.64K-97.77%-92.11K52.27%-70.54K-515.05%-98.28K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unaudited--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +5.69%
Sample Name
Sample Code
 +0.44%
Sample Name
Sample Code
 -2.38%
4
CHINA OILFIELD
02883
-3.34%
5
CNOOC
00883
-5.23%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +30.01%
Sample Name
Sample Code
 +22.47%
Sample Name
Sample Code
 +20.53%
4
Rockchip Electronics
603893
+19.38%
5
Ucloud Technology Co., Ltd
688158
+18.90%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -